We are live on
!
Find out more
BFO
Boston Family Office Portfolio holdings
AUM
$1.65B
1-Year Est. Return
18.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.28%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$659M
AUM Growth
–
Cap. Flow
+$668M
Cap. Flow
% of AUM
101.44%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
251
New
251
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$22.6M |
| 2 |
ExxonMobil
XOM
|
+$19.3M |
| 3 |
Johnson & Johnson
JNJ
|
+$16.5M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$16.4M |
| 5 |
SRCL
Stericycle Inc
SRCL
|
+$13.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.41% |
| 2 | Miscellaneous | 14.98% |
| 3 | Technology | 12.4% |
| 4 | Industrials | 12.24% |
| 5 | Consumer Staples | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $20.9M | 3.18% |
+539,199
| New | +$22.6M |
|
|
2
ExxonMobil
XOM
$679B
| $19.4M | 2.94% |
+214,277
| New | +$19.3M |
|
|
3
Johnson & Johnson
JNJ
$642B
| $16.7M | 2.54% |
+194,753
| New | +$16.5M |
|
|
4
State Street SPDR S&P 500 ETF Trust
SPY
$803B
| $16.3M | 2.47% |
+101,583
| New | +$16.4M |
|
|
SRCL
5
DELISTED
Stericycle Inc
SRCL
| $13.9M | 2.12% |
+126,214
| New | +$13.7M |
|
6
Procter & Gamble
PG
$339B
| $13M | 1.97% |
+168,282
| New | +$13.2M |
|
|
ANSS
7
DELISTED
Ansys
ANSS
| $12.8M | 1.95% |
+175,615
| New | +$13.3M |
|
8
Gilead Sciences
GILD
$182B
| $11.6M | 1.76% |
+225,545
| New | +$11.8M |
|
9
General Mills
GIS
$19.5B
| $11.3M | 1.71% |
+232,441
| New | +$11.4M |
|
|
CELG
10
DELISTED
Celgene Corp
CELG
| $11M | 1.67% |
+188,458
| New | +$11.3M |
|
11
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26B
| $10.3M | 1.56% |
+48,907
| New | +$10.3M |
|
12
Oracle
ORCL
$417B
| $9.05M | 1.37% |
+294,773
| New | +$9.78M |
|
13
Teradata
TDC
$2.73B
| $9.02M | 1.37% |
+179,651
| New | +$9.68M |
|
14
iShares Core S&P Small-Cap ETF
IJR
$107B
| $8.78M | 1.33% |
+194,324
| New | +$8.61M |
|
15
SLB Ltd
SLB
$79.1B
| $8.61M | 1.31% |
+120,124
| New | +$8.89M |
|
16
GE Aerospace
GE
$329B
| $8.47M | 1.29% |
+76,202
| New | +$8.44M |
|
17
Union Pacific
UNP
$169B
| $8.38M | 1.27% |
+108,704
| New | +$8.19M |
|
18
AptarGroup
ATR
$7.94B
| $8.26M | 1.25% |
+149,676
| New | +$8.42M |
|
19
PepsiCo
PEP
$186B
| $8.1M | 1.23% |
+99,066
| New | +$8.09M |
|
20
McDonald's
MCD
$182B
| $8.09M | 1.23% |
+81,695
| New | +$8.18M |
|
21
American Tower
AMT
$82.9B
| $8M | 1.22% |
+109,380
| New | +$8.7M |
|
|
PCL
22
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $7.99M | 1.21% |
+171,099
| New | +$8.6M |
|
23
RTX Corp
RTX
$263B
| $7.93M | 1.2% |
+135,594
| New | +$8.02M |
|
|
MRSH
24
Marsh
MRSH
$84.4B
| $7.55M | 1.15% |
+189,184
| New | +$7.4M |
|
|
MON
25
DELISTED
Monsanto Co
MON
| $7.53M | 1.14% |
+76,200
| New | +$7.98M |
|
Similar funds
MCIL
BCM
SOS
GS
NPA
AAM
OHIF
SCM
Boston Family Office's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Boston Family Office, which disclosed 251 positions worth $659M. Its ten largest holdings account for 22% of the portfolio.
Its largest position is Vanguard FTSE Emerging Markets ETF: 539,199 shares worth $20.9M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, followed by Miscellaneous and Technology.
- Boston Family Office's largest Q2 2013 buy was Vanguard FTSE Emerging Markets ETF: 539,199 shares worth $20.9M.
- Boston Family Office's ten largest holdings make up 22% of its $659M portfolio in Q2 2013.
- Boston Family Office disclosed 251 positions in Q2 2013, its first 13F filing on record.
Based on Boston Family Office's 13F filing for Q2 2013, filed 25 Jul 2013.